Neuroprotective mechanism of glial cell line-derived neurotrophic factor on dopamine neurons: Role of antioxidation

Neuropharmacology

Volumn 38, Issue 6, 1999, Pages 913-916

  Chao, C C ^a   Lee, Eminy H Y ^b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

1 Methyl 4 phenylpyridinium; Catalase; Dopamine; Glial cell line derived neurotrophic factor; Glutathione peroxidase; Superoxide dismutase

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; CATALASE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUTATHIONE PEROXIDASE; RECOMBINANT PROTEIN; SUPEROXIDE DISMUTASE;

ANIMAL MODEL; ANIMAL TISSUE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; ENZYME ACTIVITY; INTRACEREBRAL DRUG ADMINISTRATION; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SHORT SURVEY;

EID: 0032892819     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00030-1     Document Type: Article

References (10)

1. Desagher S., Glowinski J., Premont J. Astrocytes protect neurons from hydrogen peroxidase toxicity. J. Neurosci. 16:1996;2553-2562.
2. Huang T., Carlson E.J., Leadon S.A., Epstein C.J. Relationship of resistance to oxygen free radicals to CuZn-superoxide dismutase activity in transgenic, transfected, and trisomic cells. FASEB J. 6:1992;903-910.
3. Hudson J., Granholm A., Gerhardt G.A., Henry M.A., Hoffman A., Biddle P., Leela N.S., Mackerlova L., Lile J.D., Collins F., Hoffer B.J. Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo. Brain Res. Bull. 36:1995;425-432.
4. Hung H.C., Lee E.H.Y. MPTP produces differential oxidative stress and antioxidative responses in the nigrostriatal and mesolimbic dopaminergic pathways. Free Radic. Biol. Med. 24:1998;76-84.
5. Jenner P., Olanow C.W. Oxidative stress and the pathogenesis of Parkinson's disease. Neurobiology. 47:1996;S161-S170.
6. Lapchak P.A., Gash D.M., Collins F., Hilt D., Miller P.J., Araujo D. Pharmacological activities of glial cell line-derived neurotrophic factor (GDNF): prelinical development and application to the treatment of Parkinson's disease. Exp. Neurol. 145:1997;309-312.
7. Lin L.F., Doherty D.H., Lile J.D., Bektesh S., Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science. 260:1993;1130-1132.
8. Przedborki S., Kostic V., Jackson-Lewis V., Naini A.B., Simonetti S., Fahn E., Carlson E., Epstein C.J., Cadet J.L. Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J. Neurosci. 12:1992;1658-1667.
9. Tang Y.P., Ma Y.L., Chao C.C.and, Lee E.H.Y. Enhanced GDNF mRNA expression upon (-)-deprenyl and melatonin treatment. J. Neurosci. Res. 53:1998;593-604.
10. Thiffault C., Aumont N., Quirion R., Poirier J. Effects of MPTP and L-deprenyl on antioxidant enzymes and lipid peroxidation levels in mouse brain. J. Neurochem. 65:1995;2725-2733.